Literature DB >> 22790126

Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.

Atsushi Hashimoto1, Yoshiyuki Arinuma, Tatsuo Nagai, Sumiaki Tanaka, Toshihiro Matsui, Shigeto Tohma, Hirahito Endo, Shunsei Hirohata.   

Abstract

OBJECTIVE: To evaluate the incidence and risk factors for malignancy in Japanese patients with systemic sclerosis (SSc).
METHODS: A cohort of 405 Japanese patients with SSc who visited Kitasato University hospital between 1973 and 2008 was analyzed retrospectively until the end of 2009. The incidence of malignancy was compared with that of the general population, with calculation of the standardized incidence ratio (SIR) and 95% confidence interval (CI).
RESULTS: The cohort represented 4,787 person-years of total disease duration after the diagnosis of SSc. Of 27 malignancies clinically found, lung cancer (n=10, 37%), especially adenocarcinoma, was the most frequent, followed by breast (n=4, 15%) or gastric (n=3, 11%) cancer. SSc patients with overlapping CTD tended to have less malignancy. Multivariable analysis revealed heart involvement of SSc as a significant risk factor for breast cancer (RR 8.2, 95% CI 1.2-72.8). Other than gastric cancer, the calculated SIRs of malignancies in SSc patients were above 1 (SIR of overall malignancy 1.24, 95% CI 0.77-1.71), even though only lung cancer had a significantly elevated incidence (SIR 5.73, 95% CI 2.18-9.29). Every patient with lung cancer had interstitial lung disease (ILD) and every autopsy performed on patients with lung cancer found a primary lesion of lung cancer in their ILD lesion (n=4).
CONCLUSION: Lung cancer was significantly frequent in SSc patients, which could develop on the basis of complicated ILD.

Entities:  

Mesh:

Year:  2012        PMID: 22790126     DOI: 10.2169/internalmedicine.51.7686

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  9 in total

Review 1.  Cancer and Scleroderma.

Authors:  Emma Weeding; Livia Casciola-Rosen; Ami A Shah
Journal:  Rheum Dis Clin North Am       Date:  2020-06-10       Impact factor: 2.670

Review 2.  Lung cancer and interstitial lung disease: a literature review.

Authors:  Jean-Marc Naccache; Quentin Gibiot; Isabelle Monnet; Martine Antoine; Marie Wislez; Christos Chouaid; Jacques Cadranel
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

3.  Mechanistic and clinical insights at the scleroderma-cancer interface.

Authors:  Ami A Shah; Livia Casciola-Rosen
Journal:  J Scleroderma Relat Disord       Date:  2017-10-05

4.  Risk factors for malignancy in systemic sclerosis patients.

Authors:  T Kaşifoğlu; Ş Yaşar Bilge; F Yıldız; G Özen; Y Pehlivan; N Yılmaz; F Tarhan; S Yılmaz; A Küçük; H Emmungil; S S Koca; M Çınar; H Direskeneli; E Erken; G Can; M Özmen; E Gönüllü; B Kisacik; K Aksu; O Karadağ; N Kasifoglu; D Arslantas; F Sahin; G Keser; S Yavuz; M Birlik; A M Onat
Journal:  Clin Rheumatol       Date:  2016-04-27       Impact factor: 2.980

5.  Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample.

Authors:  Yaseen Alastal; Tariq A Hammad; Anas Renno; Basmah Khalil; Joel Pierre; Bismark Kwaah; Sadik A Khuder; Ali Nawras
Journal:  Ann Gastroenterol       Date:  2017-06-30

6.  Advances at the Interface of Cancer and Systemic Sclerosis.

Authors:  Christopher A Mecoli; Antony Rosen; Livia Casciola-Rosen; Ami A Shah
Journal:  J Scleroderma Relat Disord       Date:  2020-03-17

7.  Squamous Cell Lung Cancer Associated With Systemic Sclerosis.

Authors:  Nobuhiro Kanaji; Masaya Okuda; Hiroaki Dobashi; Tomohiro Kameda; Akira Tadokoro; Risa Wakiya; Norimitsu Kadowaki; Shuji Bandoh
Journal:  J Clin Med Res       Date:  2015-09-25

8.  Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature.

Authors:  M Colaci; D Giuggioli; G Cassone; C Vacchi; F Campomori; F Boselli; M Sebastiani; A Manfredi; C Ferri
Journal:  Int J Rheumatol       Date:  2015-10-18

9.  Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.

Authors:  Pia Moinzadeh; Carmen Fonseca; Martin Hellmich; Ami A Shah; Cecilia Chighizola; Christopher P Denton; Voon H Ong
Journal:  Arthritis Res Ther       Date:  2014-02-14       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.